EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Residual pain and fatigue are affected by disease perception in rheumatoid arthritis in sustained clinical and ultrasound remission

Simone Perniola, Dario Bruno, Clara Di Mario, Denise Campobasso, Martina Calabretta, Marco Gessi, Luca Petricca, Barbara Tolusso, Stefano Alivernini, Elisa Gremese

Clinical Rheumatology · 2025-03 · 44 (3) · 1019-1029

DOI: 10.1007/s10067-025-07331-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Rheumatology, online erschienen am 22.01.2025. Verfasst von Simone Perniola und 9 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Research Core Facility, Gemelli Science and Technology Park (GSTeP), Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. p…. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Fatigue, Pain. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Università Cattolica del Sacro Cuore.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Regardless of remission status, residual pain (RP) might persist in rheumatoid arthritis (RA). The aim of this study was to characterize RP, its perception, and patient-dependent features and to evaluate its possible association with residual synovitis in patients with RA in remission.

Methods

Ninety-seven patients with RA, including 68 in sustained clinical and ultrasound remission (Rem/RA) and 29 in high/moderate DAS28-CRP disease activity (H-Mo/RA) were enrolled in the study. Thirty patients with fibromyalgia were enrolled as a control group(FIBRO). At study entry, demographic, clinical, ultrasound characteristics, and pain dimension assessment (VAS-pain, FACIT, CSI, GHQ, and RAID) were collected for each patient. RA patients underwent synovial tissue biopsy to evaluate the degree of synovitis using the Krenn synovitis score (KSS).

Results

Forty-eight percent of Rem/RA still declared unacceptable pain (VAS-Pain > 20) compared to 80% of H-Mo/RA patients ( p < 0.0001). Furthermore, Rem/RA patients presented comparable levels of pain dimension assessment regardless of KSS. However, classifying Rem/RA group based on RAID score (< 2 as satisfied SAT-Rem/RA and ≥ 2 as unsatisfied UNSAT-Rem/RA), SAT-Rem/RA group presented a lower grade of VAS-Pain ( p < 0.0001), lower percentage of patients with an unacceptable pain ( p < 0.0001) and lower grade of fatigue( p < 0.0001) compared to the UNSAT-Rem/RA patients. The percentage of SAT-Rem/RA patients who presented a disease flare did not differ from UNSAT-Rem/RA over the 24 months of follow-up. Finally, female Rem/RA patients presented higher VAS-Pain compared to male Rem/RA ( p = 0.0119).

Conclusions

Moreover,73% satisfied female Rem/Ra patients presented an acceptable pain compared to 23% unsatisfied female Rem/RA patients ( p = 0.001). RP in RA patients in remission can represent the way by which the patients communicate their state of non-acceptance of the disease. It can be useful to treat RP with the appropriate treatments. Key Points • Rheumatoid arthritis patients still reported unacceptable residual pain despite sustained clinical and ultrasound remission and despite the low grade/absence of histological synovitis. • Only a small rate of rheumatoid arthritis patients in sustained clinical and ultrasound remission showed residual pain as part of a central sensitivity syndrome or psychiatric disorders. • Rheumatoid arthritis patients in sustained clinical and ultrasound remission complained residual pain and fatigue as part of not acceptance of disease and/or dissatisfaction in the disease management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidFatiguePainHumansFemaleMaleMiddle AgedAdultSynovitisPain MeasurementRemission InductionUltrasonographyAgedSeverity of Illness IndexAntirheumatic AgentsFibromyalgia

Stichwörter der Autor:innen

PainPatient-reported outcomesRemissionRheumatoid arthritis

Substanzen

Antirheumatic Agents

Autor:innen und Institutionen

  • Immunology Research Core Facility, Gemelli Science and Technology Park (GSTeP), Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. perniolasi@hotmail.it.
  • Clinical Immunology Division, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy. perniolasi@hotmail.it.
  • Clinical Immunology Division, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Medicine Department, Università Degli Studi Di Verona, Verona, Italy.
  • Immunology Research Core Facility, Gemelli Science and Technology Park (GSTeP), Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Università Cattolica del Sacro Cuore, Rome, Italy.

Förderung

  • Ministero della Salute
  • Università Cattolica del Sacro Cuore

Zitieren

APA

Perniola, S., Bruno, D., Di Mario, C., Campobasso, D., Calabretta, M., Gessi, M., Petricca, L., Tolusso, B., Alivernini, S., & Gremese, E. (2025). Residual pain and fatigue are affected by disease perception in rheumatoid arthritis in sustained clinical and ultrasound remission. Clinical Rheumatology, 44(3), 1019-1029. https://doi.org/10.1007/s10067-025-07331-0

Vancouver

Perniola S, Bruno D, Di Mario C, Campobasso D, Calabretta M, Gessi M, et al. Residual pain and fatigue are affected by disease perception in rheumatoid arthritis in sustained clinical and ultrasound remission. Clinical Rheumatology. 2025;44(3):1019-1029. doi:10.1007/s10067-025-07331-0

BibTeX
@article{Perniola2025,
  author = {Perniola, Simone and Bruno, Dario and Di Mario, Clara and Campobasso, Denise and Calabretta, Martina and Gessi, Marco and Petricca, Luca and Tolusso, Barbara and Alivernini, Stefano and Gremese, Elisa},
  title = {Residual pain and fatigue are affected by disease perception in rheumatoid arthritis in sustained clinical and ultrasound remission},
  journal = {Clinical Rheumatology},
  year = {2025},
  volume = {44},
  number = {3},
  pages = {1019--1029},
  doi = {10.1007/s10067-025-07331-0}
}
Kostenlos starten →